SPOTLIGHT -
Paul Newhouse, MD: Muscarinic Agonists in Alzheimer Treatment
The Jim Turner Chair in Cognitive Disorders at the Vanderbilt University School of Medicine shared how the previous muscarinic agonists have better informed the development of this investigational agent, VU319.
Paul Newhouse, MD: Attacking Different Targets in Alzheimer
The Jim Turner Chair in Cognitive Disorders at the Vanderbilt University School of Medicine shared his feelings on the early phase treatments.
Paul Newhouse, MD: Exploring VU319 in Alzheimer Disease
The Jim Turner Chair in Cognitive Disorders at the Vanderbilt University School of Medicine explained more about the molecule and the subsequent trial of it.
